GLEN ALLEN, Va., May 31, 2012 /PRNewswire/ -- Rock Creek
Pharmaceuticals, Inc., the manufacturer of Anatabloc® and a
subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), wishes to
extend its congratulations to Fred Couples for being named 2013
U.S. Presidents Cup Captain. Couples, who became a
spokesperson and brand ambassador for Anatabloc® in early 2012, was
named the U.S. Captain by PGA Tour Commissioner, Tim Finchem, on Tuesday at the Memorial
Tournament. The 2013 Presidents Cup will be held at Muirfield
Village Golf Club in Dublin, Ohio,
and this will be the third time Couples has served as Captain of
the U.S. team. Previously, Couples led the U.S. golf teams to
victories in San Francisco (2009)
and in Australia (2011).
(Photo: http://photos.prnewswire.com/prnh/20120531/PH16315)
(Photo: http://photos.prnewswire.com/prnh/20110830/PH59627)
(Logo:
http://photos.prnewswire.com/prnh/20120301/NE62741LOGO)
Last week, Rock Creek reported
on the retail expansion of Anatabloc® with GNC corporate
stores. In that press release, the company noted that on
June 1, 2012, GNC will begin
displaying a poster of Fred Couples
in the front window of its corporate stores in all fifty states, as
well as in the District of
Columbia and Puerto Rico. Also, Rock Creek is preparing a national television
commercial featuring Fred Couples
that it anticipates will begin airing this summer.
Additionally, as referenced in the company's recent 10-Q filing,
Star Scientific's reply to the petition for certiorari to the
Supreme Court filed by R.J. Reynolds Tobacco Company, Inc. was due
May 29, 2012. Consistent with
the schedule established for briefing at the Supreme Court, the
company's reply brief was timely filed Tuesday afternoon.
-------------------------------------------------------------------------------------------------
Certain statements contained in this release constitute
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such statements include,
but are not limited to statements identified by words such as
"believes," "expects," "anticipates," "estimates," "intends,"
"plans," "targets," "projects" and similar expressions. The
statements in this release are based upon the current beliefs and
expectations of our company's management and are subject to
significant risks and uncertainties. Actual results may differ from
those set forth in the forward-looking statements. Numerous factors
could cause or contribute to such differences, including, but not
limited to, results of clinical trials, the challenges inherent in
new product development initiatives, including the continued
development and market acceptance of our nutraceutical and low-TSNA
tobacco products, our ability to license and protect our
intellectual property, our ability to raise additional capital in
the future that is necessary to maintain our business, changes in
government policy and/or regulation, including with respect to our
nutraceutical and low-TSNA tobacco products, as well as other risks
discussed from time to time in our filings with the Securities and
Exchange Commission, including, without limitation, our annual
report on Form 10-K for the fiscal year ended December 31, 2011. We undertake no duty to update
any forward-looking statement or any information contained in this
press release or in other public disclosures at any time.
About Star Scientific
Star Scientific, Inc. is a technology-oriented company with a
mission to promote maintenance of a healthy metabolism, as well as
to reduce the harm associated with the use of tobacco at every
level. Over the last several years, through its wholly owned
subsidiary, Rock Creek Pharmaceuticals, Star Scientific has been
engaged in the manufacturing, sale, and marketing of two
nutraceutical dietary supplements, and the development of other
nutraceuticals and pharmaceuticals. The company also has continued
to pursue the development, implementation, and licensing of the
technology behind its proprietary StarCured® tobacco curing
process, which substantially prevents the formation of carcinogenic
toxins present in tobacco and tobacco smoke, primarily the
tobacco-specific nitrosamines, or TSNAs and related low-TSNA
dissolvable tobacco products. Rock Creek Pharmaceuticals has
scientific and research offices in Gloucester, MA, and a regulatory office in
Washington, DC. Star Scientific
has a Corporate and Sales Office in Glen
Allen, VA, an Executive, Scientific & Regulatory Affairs
office in Bethesda, MD, and a
manufacturing facility in Chase City,
VA.
Web: anatabloc.com l Facebook:
www.facebook.com/Anatabloc
Contact:
Talhia T. Tuck
Vice President, Communications and Investor Relations
Star Scientific, Inc.
(301) 654-8300
ttuck@starscientific.com
SOURCE Star Scientific, Inc.